EcoDrugPlus

Toll Like Receptor 2

Ensembl ID : ENSAPOG00000009494
Gene Symbol: TLR2
4 Cross references
182 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSAPOG00000022001
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSAPOG00000021967
Gene Symbol: TLR8
4 Cross references
185 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSAPOG00000013016
Gene Symbol: LOC110970507
2 Cross references
211 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAPOG00000014320
Gene Symbol: TAAR1
3 Cross references
433 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAPOG00000013531
Gene Symbol: TAAR1
2 Cross references
384 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSAPOG00000016563
Gene Symbol: LOC110962015
3 Cross references
201 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSAPOG00000003276
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSAPOG00000013838
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSAPOG00000022280
Gene Symbol: TUBA1C
4 Cross references
176 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSAPOG00000003626
Gene Symbol: LOC110956426
2 Cross references
144 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSAPOG00000006500
Gene Symbol: LOC110965288
3 Cross references
114 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).